KLRD1
Natural killer cells antigen CD94
Also known as: CD94, KLRD1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13241
- Gene
- KLRD1
- Ensembl
- ENSG00000134539
- Chromosome
- 12
- Canonical length
- 179 aa
- Protein class
- CD markers, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
Natural killer (NK) cells are a distinct lineage of lymphocytes that mediate cytotoxic activity and secrete cytokines upon immune stimulation. Several genes of the C-type lectin superfamily, including members of the NKG2 family, are expressed by NK cells and may be involved in the regulation of NK cell function. KLRD1 (CD94) is an antigen preferentially expressed on NK cells and is classified as a type II membrane protein because it has an external C terminus. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2017]
Canonical amino-acid sequenceUniProt
179 residues, UniProt reviewed canonical sequence.
>Q13241|KLRD1
1 MAVFKTTLWR LISGTLGIIC LSLMSTLGIL LKNSFTKLSI EPAFTPGPNI ELQKDSDCCS
61 CQEKWVGYRC NCYFISSEQK TWNESRHLCA SQKSSLLQLQ NTDELDFMSS SQQFYWIGLS
121 YSEEHTAWLW ENGSALSQYL FPSFETFNTK NCIAYNPNGN ALDESCEDKN RYICKQQLILocalizationUniProt · AlphaFold · HPA
Whether an antibody against KLRD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 16 nTPM
Expression across tissuesHPA
Tissue
- spleen: 16 nTPM
- bone marrow: 9.7 nTPM
- lymph node: 6.8 nTPM
- pituitary gland: 4.8 nTPM
- liver: 4.7 nTPM
- lung: 4.7 nTPM
Single-cell type
- nk-cells: 1,053 nCPM
- t-cells: 298 nCPM
- neutrophils: 147 nCPM
- choroid plexus epithelial cells: 134 nCPM
- innate lymphoid cells: 87 nCPM
- distal convoluted tubule cells: 85 nCPM
Immune cell
- NK-cell: 738 nTPM
- gdT-cell: 513 nTPM
- naive CD8 T-cell: 220 nTPM
- memory CD8 T-cell: 218 nTPM
- total PBMC: 163 nTPM
- MAIT T-cell: 58 nTPM
Brain region
- cerebellum: 27 nTPM
- cerebral cortex: 26 nTPM
- white matter: 25 nTPM
- basal ganglia: 24 nTPM
- hippocampal formation: 24 nTPM
- amygdala: 23 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.21
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.43
- DepMap mean gene effect
- 0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive immune response
- cell surface receptor signaling pathway
- natural killer cell mediated immunity
- negative regulation of natural killer cell mediated cytotoxicity
- negative regulation of T cell mediated cytotoxicity
- positive regulation of natural killer cell mediated cytotoxicity
- regulation of natural killer cell activation
- stimulatory C-type lectin receptor signaling pathway
Molecular functions
- carbohydrate binding
- HLA-A specific activating MHC class I receptor activity
- HLA-E specific inhibitory MHC class Ib receptor activity
- MHC class I protein complex binding
- MHC class Ib protein binding, via antigen binding groove
- protein antigen binding
- transmembrane signaling receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of KLRD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads KLRD1 as an antibody target. Whether an autoantibody or antibody against KLRD1 could matter depends on whether native KLRD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
KLRD1 is annotated at the cell surface, where native KLRD1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label KLRD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...